Number of isolates tested for ciprofloxacin in United States of America
United States of America: Number of isolates tested for ciprofloxacin was 5,160 in 2018. ▼ Falling
Latest (2018)
5,160
Change on year
up 2.0%
World rank
2nd
of 54 countries
All-time high
5,945
in 2013
All-time low
5,061
in 2017
Years of data
10
2009–2018
Number of isolates tested for ciprofloxacin in United States of America, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
In 2018, number of isolates tested for ciprofloxacin in United States of America stood at 5,160.
Compared with earlier readings it is up 2.0% on the previous year and down 8.3% over ten years.
Over the whole period, number of isolates tested for ciprofloxacin in United States of America peaked at 5,945 in 2013 and was at its lowest, 5,061, in 2017.
United States of America ranks 2nd of 54 countries on this measure, in the top 10%.
Number of isolates tested for ciprofloxacin in United States of America, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 5,630 | — |
| 2010 | 5,693 | +1.1% |
| 2011 | 5,467 | -4.0% |
| 2012 | 5,495 | +0.5% |
| 2013 | 5,945 | +8.2% |
| 2014 | 5,093 | -14.3% |
| 2015 | 5,147 | +1.1% |
| 2016 | 5,256 | +2.1% |
| 2017 | 5,061 | -3.7% |
| 2018 | 5,160 | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5,630 | 5,630 | 5,630 | 1 |
| 2010s | 5,369 | 5,061 | 5,945 | 9 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0277 units per person (2025)
- Population ages 05-09, male, annual growth rate -1.74 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0291 units per person (2025)
- Population ages 10-14, female, annual growth rate -0.6756 % change on previous year (2025)
Frequently asked questions
- What is number of isolates tested for ciprofloxacin in United States of America?
- Number of isolates tested for ciprofloxacin in United States of America was 5,160 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest number of isolates tested for ciprofloxacin recorded in United States of America?
- The highest recorded value was 5,945 in 2013.
- What is the lowest number of isolates tested for ciprofloxacin recorded in United States of America?
- The lowest recorded value was 5,061 in 2017.
- How does United States of America rank for number of isolates tested for ciprofloxacin?
- United States of America ranks 2nd out of 54 countries with data for 2018.
- Is number of isolates tested for ciprofloxacin rising or falling in United States of America?
- Over the last ten years it is down 8.3%. The long-run trend across the full record is falling.
- Where does this United States of America data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Number of isolates tested for ciprofloxacin. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).